Humana to Divest Minority Interest in Gentiva in Deal Valuing Interest at Approximately $900 Million

Humana entered into a definitive agreement to divest all or substantially all of its minority interest in Gentiva, an end-of-life care provider. The agreement values Humana’s minority stake at approximately $900 million, with proceeds intended for general corporate purposes; the transaction is expected to close in Q3 2026 subject to approvals.